{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:01:38Z","timestamp":1790236898765,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcmd.2026.103038","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:04:06Z","timestamp":1789052646000},"page":"103038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evolution and Hospitalization Determinants of Homozygous Sickle Cell Disease in Semi-Rural Gabon"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0789-7769","authenticated-orcid":false,"given":"No\u00e9","family":"Essono-Kollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis Jolinom","family":"Mbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette Ornely Orango","family":"Bourdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodeney Boukeghet","family":"Boungou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Avoume Ella Missang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morel Essono","family":"Mintsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph-Arnold","family":"Obiang-Nze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric Sima","family":"Obiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy Roger Ndong","family":"Atome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Privat","family":"Ondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucr\u00e8ce M.","family":"Delicat Loembet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Nagalo Bolni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Cl\u00e9ment","family":"Obame Engonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bcmd.2026.103038_bb0005","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Thomson","year":"2023","journal-title":"Lancet Haematol."},{"issue":"S1","key":"10.1016\/j.bcmd.2026.103038_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ijlh.13023","article-title":"Sickle cell disease: Reducing the global disease burden","volume":"41","author":"Mburu","year":"2019","journal-title":"Int J Lab Hematology."},{"issue":"2","key":"10.1016\/j.bcmd.2026.103038_bb0015","first-page":"1","article-title":"Diagnosis of sickle cell disease in Gabon using sickle SCAN\u00ae: a point-of-care blood test","volume":"6","author":"Delicat-Loembet","year":"2022","journal-title":"International Journal of Translational Medical Research and Public Health."},{"key":"10.1016\/j.bcmd.2026.103038_bb0020","series-title":"R\u00e9sultats globaux du Recensement G\u00e9n\u00e9ral de la Population et des Logements de 2013 DU Gabon (RGPL2013)","author":"RGPL","year":"2013"},{"issue":"Suppl","key":"10.1016\/j.bcmd.2026.103038_bb0025","doi-asserted-by":"crossref","first-page":"A51","DOI":"10.1016\/j.revmed.2020.10.085","article-title":"Population dr\u00e9panocytaire adulte suivie dans un centre de r\u00e9f\u00e9rence de la dr\u00e9panocytose adulte fran\u00e7ais: \u00e9tude transversale descriptive (2017\u20132018)","volume":"41","author":"Meunier","year":"2020","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.bcmd.2026.103038_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.bcmd.2026.103038_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bcmd.2026.103038_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/03630269.2023.2211771","article-title":"Novel insights into the pathophysiology and treatment of sickle cell disease","volume":"47","author":"Ara\u00fajo","year":"2023","journal-title":"Hemoglobin"},{"issue":"10533","key":"10.1016\/j.bcmd.2026.103038_bb0045","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(25)02278-0","article-title":"Sickle cell disease","volume":"407","author":"Colombatti","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2026.103038_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1578570","article-title":"Findings supporting neonatal screening for sickle cell disease: an observational study in Senegal","volume":"13","author":"Petigas","year":"2025","journal-title":"Front. Pediatr."},{"issue":"9","key":"10.1016\/j.bcmd.2026.103038_bb0055","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1182\/bloodadvances.2026019796","article-title":"Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA)","volume":"10","author":"Awuonda","year":"2026","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.bcmd.2026.103038_bb0060","doi-asserted-by":"crossref","DOI":"10.1182\/hem.V23.1.2026110","article-title":"Sickle cell disease in 2025: sustained progress amid challenges","volume":"23","author":"Wilson","year":"2026","journal-title":"Hematologist"},{"issue":"9","key":"10.1016\/j.bcmd.2026.103038_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305110","article-title":"Sustainability of newborn screening for sickle cell disease in resource-poor countries: A systematic review","volume":"19","author":"Okeke","year":"2024","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.bcmd.2026.103038_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10245332.2000.11746536","article-title":"The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease","volume":"5","author":"Wun","year":"2000","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2026.103038_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2022.102703","article-title":"Plasma immune mediators as laboratorial biomarkers for Sickle Cell Disease patients according to the hydroxyurea therapy and disease severity","volume":"98","author":"De Oliveira Toledo","year":"2023","journal-title":"Blood Cells Mol. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2026.103038_bb0080","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2023-188652","article-title":"Availability and cost of basic drugs for sickle cell disease in 13 African countries","volume":"142","author":"Keza","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2026.103038_bb0085","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00277-024-06180-2","article-title":"Use of hydroxyurea in French-speaking Sub-Saharan Africa","volume":"104","author":"Arlet","year":"2025","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2026.103038_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.103038_bb0095","unstructured":"Drugs.com. [Internet], Hydroxyurea dosage guide + max dose, adjustments. Last updated Feb 2, 2026. Available from: https:\/\/www.drugs.com. (Accessed 14 June 2026)."},{"key":"10.1016\/j.bcmd.2026.103038_bb0100","author":"Tous \u00e0 l\u2019\u00e9cole"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:46:35Z","timestamp":1790235995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":20,"alternative-id":["S1079979626000616"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103038","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution and Hospitalization Determinants of Homozygous Sickle Cell Disease in Semi-Rural Gabon","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103038"}}